Daily Care News for November 23, 2022
advertisement
- Type 1 Diabetes: The Benefits and Limitations of a Pancreas Transplant
- Increased T1DM risk in children infected with SARS-CoV-2
- Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study
- Hybrid Closed Loop Insulin Pump Technology Can Be Safely Used In The Inpatient Setting
- COVID-19 and Incident Type 1 Diabetes: Deciphering the Associations
- Protocol for the Promoting Resilience in Stress Management (PRISM) intervention: A multi-site randomized controlled trial for adolescents with type 1 diabetes
- Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes
- The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
- Mediating Effects of Technology-based Therapy on the Relationship between Socioeconomic Status & Glycemic Management in Pediatric Type 1 Diabetes
- Attendance at pre-pregnancy care clinics for women with type 1 diabetes: a scoping review
- Barriers to Physical Activity in Children and Adults Living With Type 1 Diabetes: A Complex Link With Real-life Glycemic Excursions
- FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes
- Serum iron is negatively correlated with the HbA1c level in children and adolescents with type 1 diabetes mellitus (Full text HTML, PDF)
- A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases (Full text HTML, PDF)
- Diet consistency modification improves postprandial glycemic and gastroparesis symptoms
- Parental marital relationship satisfaction is associated with glycemic outcomes in children with type 1 diabetes (Full text HTML, PDF)
- The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring, snacking habits, sleep extension and values-guided self-care interventions to improve glucose time-in-range in young people (13-20 years) with type 1 diabetes (Full text HTML, PDF)
- Pre-pregnancy Health of Women with Pre-existing Diabetes or Previous Gestational Diabetes; analysis of pregnancy risk factors and behavioural data from a digital tool
- Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index
- A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system
- Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes
- Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection (Full text HTML, PDF)
- Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease
- Impact of glycemic variability on cognitive impairment, disordered eating behaviors and self-management skills in patients with type 1 diabetes: study protocol for a cross-sectional online study, the Sugar Swing study (Full text HTML, PDF)
- Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes – the Dialong study
- Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature
- Healthcare of pregnant women with diabetes during the COVID-19 pandemic: a Southern Brazilian cross-sectional panel data
- The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
- Open-source automated insulin delivery in type 1 diabetes—the evidence is out there
